• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用噬菌体展示技术鉴定RON酪氨酸激酶受体结合肽及其结合模式的计算建模

Identification of a RON tyrosine kinase receptor binding peptide using phage display technique and computational modeling of its binding mode.

作者信息

Zarei Omid, Benvenuti Silvia, Ustun-Alkan Fulya, Hamzeh-Mivehroud Maryam, Dastmalchi Siavoush

机构信息

Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.

Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

J Mol Model. 2017 Aug 19;23(9):267. doi: 10.1007/s00894-017-3437-2.

DOI:10.1007/s00894-017-3437-2
PMID:28823053
Abstract

RON (Recepteur d'Origine Nantais) tyrosine kinase receptor is a promising target for therapeutic intervention in cancer therapy. The aim of this work was identification of RON-binding peptides using phage display and computational modeling their mode of binding. A 12-mer peptide phage library was utilized to perform biopanning against RON. The RON-binding ability of the selected peptide-displaying phage and their possible binding sites were examined by ELISA. Binding modes and affinities were also predicted by docking and molecular dynamics (MD) simulation. The results of ELISA experiment showed that P6 peptide displaying phage has higher affinity for RON compared to others and its binding site is located out of ligand binding site. Docking and MD simulation results also indicated higher affinity of P6 to RON as well as its exosite-binding feature. Taken together, our data suggest a capacity for P6 peptide (FEHSLYKEMTHL) to be utilized as RON binding agent, and hence be used for various purposes, including design of drug delivery systems for transferring cytotoxic agents to RON-positive cancer cells, interfering with RON signaling, peptidomimetics design, and diagnostic imaging.

摘要

RON(源自南特的受体)酪氨酸激酶受体是癌症治疗中一个有前景的治疗干预靶点。这项工作的目的是利用噬菌体展示技术鉴定RON结合肽,并通过计算模拟其结合模式。利用一个12肽噬菌体文库对RON进行生物淘选。通过酶联免疫吸附测定(ELISA)检测所选展示肽噬菌体的RON结合能力及其可能的结合位点。还通过对接和分子动力学(MD)模拟预测结合模式和亲和力。ELISA实验结果表明,与其他噬菌体相比,展示P6肽的噬菌体对RON具有更高的亲和力,其结合位点位于配体结合位点之外。对接和MD模拟结果也表明P6对RON具有更高的亲和力及其别构结合特征。综上所述,我们的数据表明P6肽(FEHSLYKEMTHL)有能力用作RON结合剂,因此可用于各种目的,包括设计将细胞毒性剂转运至RON阳性癌细胞的药物递送系统、干扰RON信号传导、肽模拟物设计和诊断成像。

相似文献

1
Identification of a RON tyrosine kinase receptor binding peptide using phage display technique and computational modeling of its binding mode.利用噬菌体展示技术鉴定RON酪氨酸激酶受体结合肽及其结合模式的计算建模
J Mol Model. 2017 Aug 19;23(9):267. doi: 10.1007/s00894-017-3437-2.
2
Structural basis for the binding specificity of human Recepteur d'Origine Nantais (RON) receptor tyrosine kinase to macrophage-stimulating protein.人源南特起源受体(RON)受体酪氨酸激酶与巨噬细胞刺激蛋白结合特异性的结构基础
J Biol Chem. 2014 Oct 24;289(43):29948-60. doi: 10.1074/jbc.M114.594341. Epub 2014 Sep 5.
3
The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells.RON受体酪氨酸激酶促进乳腺上皮细胞中不依赖于巨噬细胞刺激蛋白的细胞铺展和存活。
Oncogene. 2009 Jan 15;28(2):279-88. doi: 10.1038/onc.2008.383. Epub 2008 Oct 6.
4
Curcumin blocks RON tyrosine kinase-mediated invasion of breast carcinoma cells.姜黄素可阻断RON酪氨酸激酶介导的乳腺癌细胞侵袭。
Cancer Res. 2008 Jul 1;68(13):5185-92. doi: 10.1158/0008-5472.CAN-07-6883.
5
STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family.STK/RON受体酪氨酸激酶通过HGF受体家族中保守的多功能对接位点介导凋亡信号和生长信号。
EMBO J. 1996 Nov 1;15(21):5866-75.
6
Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo.鉴定一种具有体内抗肿瘤活性的新型南特受体/ c- met小分子激酶抑制剂。
Cancer Res. 2008 Aug 15;68(16):6680-7. doi: 10.1158/0008-5472.CAN-07-6782.
7
Characterization of two monoclonal antibodies against the RON tyrosine kinase receptor.两种抗RON酪氨酸激酶受体单克隆抗体的特性分析
Hybridoma. 1998 Dec;17(6):541-51. doi: 10.1089/hyb.1998.17.541.
8
Ligand-based Discovery of Novel Small Molecule Inhibitors of RON Receptor Tyrosine Kinase.基于配体的新型小分子 RON 受体酪氨酸激酶抑制剂的发现。
Mol Inform. 2022 Jan;41(1):e2000181. doi: 10.1002/minf.202000181. Epub 2020 Dec 4.
9
Characterizing the Hot Spots Involved in RON-MSPβ Complex Formation Using Alanine Scanning Mutagenesis and Molecular Dynamics Simulation.利用丙氨酸扫描诱变和分子动力学模拟表征RON-MSPβ复合物形成过程中的热点
Adv Pharm Bull. 2017 Apr;7(1):141-150. doi: 10.15171/apb.2017.018. Epub 2017 Apr 13.
10
Identification of new peptide ligands for epidermal growth factor receptor using phage display and computationally modeling their mode of binding.利用噬菌体展示技术鉴定表皮生长因子受体的新肽配体,并通过计算建模其结合模式。
Chem Biol Drug Des. 2012 Mar;79(3):246-59. doi: 10.1111/j.1747-0285.2011.01282.x. Epub 2012 Jan 11.

引用本文的文献

1
Enhanced biosorption of cadmium ions on immobilized surface-engineered yeast using cadmium-binding peptides.利用镉结合肽增强固定化表面工程酵母对镉离子的生物吸附作用。
Front Microbiol. 2024 Nov 15;15:1496843. doi: 10.3389/fmicb.2024.1496843. eCollection 2024.
2
Enhanced Biosorption of Nickel Ions on Immobilized Surface-Engineered Yeast Using Nickel-Binding Peptides.使用镍结合肽增强固定化表面工程酵母对镍离子的生物吸附作用。
Front Microbiol. 2019 Jun 26;10:1254. doi: 10.3389/fmicb.2019.01254. eCollection 2019.

本文引用的文献

1
Recent Innovations in Peptide Based Targeted Drug Delivery to Cancer Cells.基于肽的癌细胞靶向给药的最新创新成果。
Biomedicines. 2016 May 26;4(2):11. doi: 10.3390/biomedicines4020011.
2
Targeting kinase signaling pathways with constrained peptide scaffolds.用受限肽支架靶向激酶信号通路。
Pharmacol Ther. 2017 May;173:159-170. doi: 10.1016/j.pharmthera.2017.02.014. Epub 2017 Feb 7.
3
Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides.利用细胞穿透肽和肿瘤靶向肽进行抗癌药物传递的最新进展。
J Control Release. 2017 Mar 28;250:62-76. doi: 10.1016/j.jconrel.2017.02.006. Epub 2017 Feb 4.
4
Selection of antitumor displayed peptides for the specific delivery of the anticancer drug lactaptin.用于抗癌药物乳杆菌素特异性递送的抗肿瘤展示肽的筛选。
Oncol Lett. 2016 Dec;12(6):4547-4555. doi: 10.3892/ol.2016.5266. Epub 2016 Oct 14.
5
Characterization of particulate matter binding peptides screened from phage display.从噬菌体展示中筛选出的颗粒物结合肽的表征
J Biosci Bioeng. 2017 May;123(5):621-624. doi: 10.1016/j.jbiosc.2016.12.014. Epub 2017 Jan 13.
6
RON Signaling Is a Key Mediator of Tumor Progression in Many Human Cancers.RON信号传导是多种人类癌症肿瘤进展的关键介质。
Cold Spring Harb Symp Quant Biol. 2016;81:177-188. doi: 10.1101/sqb.2016.81.031377. Epub 2017 Jan 5.
7
A CD13-targeting peptide integrated protein inhibits human liver cancer growth by killing cancer stem cells and suppressing angiogenesis.一种靶向CD13的肽整合蛋白通过杀死癌症干细胞和抑制血管生成来抑制人类肝癌生长。
Mol Carcinog. 2017 May;56(5):1395-1404. doi: 10.1002/mc.22600. Epub 2017 Jan 4.
8
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 32 种癌症组别的伤残调整生命年数,1990 年至 2015 年:全球疾病负担研究的系统分析。
JAMA Oncol. 2017 Apr 1;3(4):524-548. doi: 10.1001/jamaoncol.2016.5688.
9
Advances in Cancer Therapy: Targeted Therapies.癌症治疗进展:靶向治疗
Oncol Res Treat. 2016;39(12):758-759. doi: 10.1159/000453340. Epub 2016 Nov 24.
10
Discovery of an artificial peptide agonist to the fibroblast growth factor receptor 1c/βKlotho complex from random peptide T7 phage display.通过随机肽T7噬菌体展示发现成纤维细胞生长因子受体1c/βKlotho复合物的人工肽激动剂。
Biochem Biophys Res Commun. 2016 Nov 4;480(1):55-60. doi: 10.1016/j.bbrc.2016.10.009. Epub 2016 Oct 4.